Correlation Between Regenxbio and Capricor Therapeutics
Can any of the company-specific risk be diversified away by investing in both Regenxbio and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenxbio and Capricor Therapeutics, you can compare the effects of market volatilities on Regenxbio and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and Capricor Therapeutics.
Diversification Opportunities for Regenxbio and Capricor Therapeutics
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Regenxbio and Capricor is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Regenxbio i.e., Regenxbio and Capricor Therapeutics go up and down completely randomly.
Pair Corralation between Regenxbio and Capricor Therapeutics
Given the investment horizon of 90 days Regenxbio is expected to under-perform the Capricor Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Regenxbio is 1.47 times less risky than Capricor Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The Capricor Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 472.00 in Capricor Therapeutics on November 27, 2024 and sell it today you would earn a total of 973.00 from holding Capricor Therapeutics or generate 206.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Regenxbio vs. Capricor Therapeutics
Performance |
| Timeline |
| Regenxbio |
| Capricor Therapeutics |
Regenxbio and Capricor Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Regenxbio and Capricor Therapeutics
The main advantage of trading using opposite Regenxbio and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.| Regenxbio vs. Day One Biopharmaceuticals | Regenxbio vs. Replimune Group | Regenxbio vs. Mirum Pharmaceuticals | Regenxbio vs. Rocket Pharmaceuticals |
| Capricor Therapeutics vs. Bio Path Holdings | Capricor Therapeutics vs. NextCure | Capricor Therapeutics vs. Pulmatrix | Capricor Therapeutics vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |